AnaptysBio (ANAB) PT Lowered to $93 at Piper Sandler
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $57.74 +1.85%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi lowered the price target on AnaptysBio (NASDAQ: ANAB) to $93.00 (from $95.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Beijing Kingsoft Office Software Inc (688111:CH) PT Lowered to RMB303 at Jefferies
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- China Resources Beer Holdings Co Ltd. (291:HK) (CRHKY) PT Lowered to HK$31 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
